| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 28,000 | 01 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000114036123010162-murray-christine-2023-03-01 | Eiger BioPharmaceuticals, Inc. | 01 Mar 2023 | 1 | $0 | 4 | Director | 03 Mar 2023, 19:50 |
| /report/000156761923000069-murray-christine-2022-12-29 | Eiger BioPharmaceuticals, Inc. | 29 Dec 2022 | 1 | -$6,104 | 4 | Director | 03 Jan 2023, 19:30 |
| /report/000114036122009261-murray-christine-2022-03-11 | Eiger BioPharmaceuticals, Inc. | 11 Mar 2022 | 2 | $0 | 4 | Director | 11 Mar 2022, 20:06 |